DENDRITIC MESOPOROUS SILICA NANOPARTICLES SYNTHESIZED VIA A FACILE ONE-POT SURFACTANT-FREE PROCESS

Abstract

A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles. The silica precursor may comprise tetraethyl orthosilicate (TEOS), the one or more polymer precursors may comprise 3-aminophenol and formaldehyde and the compound may be ethylene diamine (EDA). There is a window of amount of EDA present that will result in asymmetric particles being formed. If a greater amount of EDA is present, symmetrical particles will be formed.

Claims

1-41. (canceled)

42. A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles.

43. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors enhances interaction between the primary silica particles and the polymer or oligomers formed from the one or more polymer precursors, or the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors acts as a binder to facilitate deposition of a polymer or oligomer formed from the one or more polymer precursors on the primary silica particles, or the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors reacts with the silica precursor or reacts with silicate formed from the silica precursor, or facilitates reaction between the silica precursor or silicate formed from the silica precursor and the one or more polymer precursors or polymers or oligomers formed from the one or more polymer precursors.

44. A method as claimed in claim 42 wherein the silica precursor comprises a silica precursor that reacts more quickly than the one or more polymer precursors such that a primary silica particle is initially formed, followed by formation of further silica and polymer or oligomers that are laid down on the primary silica particles to result in formation of particles that comprise the primary silica particles having extra silica and polymer growing from the surface thereof, and once the reactants have been consumed or the particles removed from the reaction mixture, the particles are treated to either remove the carbon-containing components or remove the silica containing components to form dendritic silica mesoporous nanoparticles or dendritic carbon mesoporous nanoparticles, respectively.

45. A method as claimed in claim 42 wherein the one or more polymer precursors start to form polymers or oligomers after nucleation of silica has started.

46. A method as claimed in claim 45 wherein the one or more polymer precursors must overcome an energy barrier for nucleation before polymers or oligomers start to form.

47. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors is present in an amount such that heterogeneous nucleation of polymer and silica on the primary silica particles is promoted and symmetrical nanoparticles are obtained.

48. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors is present in an amount such that formation of a region of polymer or oligomer on a surface of the primary silica particles is formed, with further polymer or oligomer growing on the region of polymer or oligomer whilst further silica grows on the remaining surface of the primary silica particles, followed by the silica precursor reacting with oligomers polymers formed from the one or more polymeric precursors whereby oligomers containing silicate and the one or more polymer precursors or oligomers thereof deposit on the silica surface of the primary particles and asymmetric nanoparticles are formed.

49. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors is a positively charged compound or has a net positive surface charge.

50. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors comprises an organic amine.

51. A method as claimed in claim 50 wherein the organic amine is an alkyl, alkene, alkyne or aryl amine, or an alkyl, alkene, alkyne or aryl diamine, or an alkyl, alkene, alkyne or aryl triamine, or ethylene diamine.

52. A method as claimed in claim 42 wherein the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors comprises a compound that converts a negatively charged silica surface to a positively charged surface and then binds to the polymer/oligomer matrix.

53. A method as claimed in claim 52 wherein the compound comprises cetyltrimethylammonium bromide.

54. A method as claimed in claim 42 wherein the polymer that is formed is negatively charged or has a net negative surface charge and the compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors has a positive charge or a net positive surface charge.

55. A method as claimed in claim 42 wherein the one or more polymer precursors comprise resorcinol-formaldehyde, aminophenol-formaldehyde or dopamine.

56. A method as claimed in claim 42 wherein the silica precursor comprises tetraethyl orthosilicate (TEOS), tetrapropyl orthosilicate (TPOS) or tetrabutoxysilane (TBOS), tetramethyl orthosilicate (TMOS).

57. A method as claimed in claim 42 wherein the reaction mixture further comprises an alcohol and water.

58. A method as claimed in claim 57 wherein the alcohol comprises ethanol.

59. A method as claimed in claim 42 wherein the reaction mixture includes an alkali material.

60. A method as claimed in claim 59 wherein the alkali material comprises ammonia.

61. A method as claimed in claim 42 wherein the reaction occurs at an alkaline or basic pH.

62. A method as claimed in claim 61 wherein the reaction takes place at a pH in the range of from about 8 to 11.

63. A method as claimed in claim 42 wherein the compound comprises ethylenediamine (EDA) and the one or more polymer precursors comprise 3-aminophenol and formaldehyde.

64. A method as claimed in claim 63 wherein the mass ratio of EDA to (3-aminophenol and formaldehyde) falls within a range of from 0.20 to 0.28, or from 0.23 to 0.27, in order to form asymmetric particles.

65. A method as claimed in claim 63 wherein the mass ratio of EDA to (3-aminophenol and formaldehyde) is greater than 0.28 or greater than 0.29, and symmetrical particles are formed.

66. A method as claimed in claim 42 wherein the silica precursor comprises tetraethyl orthosilicate (TEOS) and the one or more polymer precursors comprise 3-aminophenol and formaldehyde and the compound is ethylene diamine (EDA) and the molar ratio of EDA to TEOS falls within a range of from 0.20 to 0.46, in order to form asymmetric particles.

67. A method as claimed in claim 42 wherein the silica precursor comprises tetraethyl orthosilicate (TEOS) and the one or more polymer precursors comprise 3-aminophenol and formaldehyde and the compound is ethylene diamine (EDA) and the molar ratio of EDA to TEOS is greater than 0.46 to symmetrical particles will be formed.

68. A method as claimed in claim 42 wherein the reaction takes place at temperatures in the range of from 0° to 75° C.

69. A method as claimed in claim 42 wherein the particles are removed or separated from the liquid phase, washed and dried and then treated to form either silica nanoparticles or carbon nanoparticles.

70. A method as claimed in claim 42 wherein in order to form silica nanoparticles, the particles are calcined in air or an oxygen containing atmosphere to thereby burn out the polymer, leaving behind the silica nanoparticles.

71. A method as claimed in claim 70 wherein calcination takes place at a temperature of from 500° to 1000° C., or from 500° to 700° C.

72. A method as claimed in claim 42 wherein in order to form carbon nanoparticles, the particles are carbonised by heating in an inert or reducing atmosphere or in an atmosphere that is essentially free of oxygen to carbonise the polymer, followed by selective leaching/etching of the silica from the particles.

73. A method as claimed in claim 72 wherein the selective leaching/etching of the silicon from the particles is achieved using hydrofluoric acid.

74. A method as claimed in claim 42 wherein asymmetric nanoparticles are formed and the particles may have a maximum particle size of up to 1000 nm, or up to 900 nm, or up to 800 nm.

75. A method as claimed in claim 74 wherein the particles have a minimum particle size of 100 nm, or 150 nm, or 200 nm.

76. A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that enhances interaction between the primary silica particles and the polymer or oligomers formed from the one or more polymer precursors, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles.

77. A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that acts as a binder to facilitate deposition of a polymer or oligomer formed from the one or more polymer precursors on the primary silica particles, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles.

78. A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that reacts with the silica precursor or reacts with silicate formed from the silica precursor, or facilitates reaction between the silica precursor or silicate formed from the silica precursor and the one or more polymer precursors or polymers or oligomers formed from the one or more polymer precursors, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles.

79. Symmetrical silica nanoparticles comprising a solid core having outgrowths of silica extending from the solid core.

80. Symmetrical carbon nanoparticles comprising a hollow core having outgrowths of carbon extending from the hollow core.

81. Symmetrical carbon nanoparticles as claimed in claim 80 wherein the hollow core is mesoporous.

Description

BRIEF DESCRIPTION OF DRAWINGS

[0044] Various embodiments of the invention will be described with reference to the following drawings, in which:

[0045] FIG. 1 shows (A) and (B) TEM images and (C) SEM image of the monodisperse mesa porous silicon nanoparticles of example 1;

[0046] FIG. 2 shows N.sub.2 adsorption/desorption isotherms and the corresponding pore size distributions (inset) of the monodisperse mesoporous silicon nanoparticles of example 1;

[0047] FIG. 3 shows TEM, SEM and STEM EDS mapping images of the prepared ABC heterotrimeric nanoparticles. (a, b) TEM images; (c) SEM image; (d) HAADF-STEM image; (e-i) EDX elemental mapping of C, N, O, Si and colour overlays, respectively, of the nanoparticles obtained in example 2;

[0048] FIG. 4 shows TEM (a, c) and SEM (b, d) images of the asymmetric nanoparticles. (a, b) asymmetric silica nanoparticles, (c, d) asymmetric carbon nanoparticles;

[0049] FIG. 5 shows N.sub.2 sorption isotherm (A) and pore size distribution (B) of (a) Asymmetric carbon nanoparticles, (b) Asymmetric silica nanoparticles, (c) ABC heterotrimeric nanoparticles;

[0050] FIG. 6 shows tilting TEM images of (a, b) ABC heterotrimeric nanoparticle (from +120° to 0°), (d, e) asymmetric silica nanoparticle (from 0° to +90°) and (g, h) asymmetric carbon nanoparticle (from −55° to +55°). ET slides of (c) ABC heterotrimeric nanoparticle, (f) asymmetric silica nanoparticle, and (i) asymmetric carbon nanoparticle;

[0051] FIG. 7 shows TEM images of morphological evolution of the ABC heterotrimeric nanoparticle collected at different reaction time. (a) 5 min; (b) 10 min; (c) 15 min; (d) 30 min; (e) 1 h; (f) 3 h.

[0052] FIG. 8 shows TEM images of morphological evolution of the calcined sample of ABC heterotrimeric nanoparticles collected at different reaction time. (a) 5 min; (b) 10 min; (c) 15 min; (d) 30 min; (e) 1 h; (f) 3 h;

[0053] FIG. 9 shows TEM images of morphological evolution of the calcined sample of the carbon product of ABC heterotrimeric nanoparticles synthesized at different reaction time. (a) 5 min; (b) 10 min; (c) 15 min; (d) 30 min; (e) 1 h; (f) 3 h;

[0054] FIG. 10 shows TEM images of APF-silica nanoparticle with different amount of EDA. (a,b,c) 0 mL; (d,e,f) 0.200 mL; (g,h,i) 0.215 mL. As synthesized samples (a,d,g), calcined samples (b,e,h), carbonized and HF etched samples (c,f,i);

[0055] FIG. 11 shows time dependent cellular uptake of asymmetric silica and symmetric silica nanoparticles in four cell lines investigated by ICP-OES. RAW 264.7 cells (a); HCT116 cells (b); CHO-K1 cells (c); KHOS cells (d);

[0056] FIG. 12 shows fluorescent and merged images of RAW 264.7 and HCT116 cell lines, after the addition of the asymmetric silica and symmetric silica nanoparticles, being fixed at 0.5 or 4 hours and stained for polymerized actin with RH phalloidin. Scale bar, 20 μm;

[0057] FIG. 13 shows fluorescent and merged images of CHO-K1 and KHOS cell lines, after the addition of the asymmetric silica and symmetric silica nanoparticles, being fixed at 0.5 or 4 hours and stained for polymerized actin with RH phalloidin. Scale bar, 20 μm; and

[0058] FIG. 14 shows cellular uptake of the asymmetric silica nanoparticle and the symmetric silica nanoparticle in RAW 264.7 cells (a); HCT116 cells (b); CHO-K1 cells (c); KHOS cells (d) cell lines as determined by Fluorescence-activated cell sorting (FACS) analysis.

DESCRIPTION OF EMBODIMENTS

Example 1—Preparation of Symmetric Particles

[0059] Monodisperse mesoporous silica nanoparticles were synthesized via a facile one-pot, surfactant-free process under the well-known Stöber synthesis condition. Typically, an aqueous-alcoholic solution was prepared by mixing ethanol (40 mL), distilled water (10 mL), ammonium hydroxide (1.56 mL) and ethylenediamine solution (EDA, 0.225 mL) under stirring at 60° C. After that, 3-aminophenol (0.412 g), formaldehyde solution (0.9 mL), TEOS (1.56 mL) were added to the above-mentioned solution. Then the mixture was vigorously stirred for 5 h. The as synthesized composite was collected by centrifugation, ethanol washing and drying. Finally, monodisperse mesoporous silica nanoparticles were harvested after calcination in air, noted as DMSN-M.

[0060] TEM images (FIG. 1A) showed that the well dispersed silicon nanoparticles with a uniform morphology are obtained. As shown in FIG. 1B, the mean particle diameter is approximately 180+ or −5 nm in the particles exhibit nano-sized radial spikes. An SEM image (FIG. 1C) further shows the uniform size silicon nanoparticles with a dense distribution of silica spikes. The nitrogen adsorption and desorption isotherm (FIG. 2) shows a typical type IV isotherm with distinct hysteresis loops, which indicates the existence of a high degree of miso porosity. The corresponding Barrett-Joyner-Halenda (BJH) pore size distribution curve (FIG. 2, the insert curve, derived from the adsorption breads exhibits a relatively broad peak centred at 9.1 nm.

Example 2—a Bottom-Up Self Assembly of AV+BC Heterotrimeric Nanoparticles Vis a Facile One-Pot Approach

[0061] As shown in FIG. 3a, the synthesis involves three molecular precursors: 3-aminophenol (AP), formaldehyde (F), tetraethyl orthosilicate (TEOS) in a basic solution containing ethylenediamine (EDA), ethanol, water and ammonia. The hydrolysis and condensation of TEOS firstly results in the formation of silica primary particles.sup.51 and then Stober silica spheres.sup.52 as a building block A. The polymerization of AP and F leads to APF oligomers, which further nucleate as a building block B preferentially on one side of A, leading to an AB heterodimeric structure with the sizes of both A and B blocks increasing with time. Afterwards, silica primary particles and APF oligomers co-condense, forming a building block C on the other side of A. Eventually an ABC type heterotrimeric nanoparticle with an acorn-like asymmetric morphology is constructed, which can be used to generate two different second-generation asymmetric nanoparticles (FIG. 3b): one asymmetric silica nanoparticle by calcination to remove APF polymer, another asymmetric carbon nanoparticle by carbonization in an inert atmosphere followed by selective silica etching. In addition, for the first time, we demonstrate that the nanoparticle cellular uptake is dependent on both nanoparticle symmetry and the phagocytic capacity of cells (FIG. 3c). Symmetry-polarized cellular take is preferred in cell lines with low phagocytic ability (e.g., KHOS and CHO-K1 cells), while asymmetry-polarized cellular uptake is advantageous in cell lines with high phagocytic ability (e.g., HCT116 and RAW264.7 cells).

[0062] Synthesis of the ABC Heterotrimeric Nanoparticles.

[0063] Monodispersed ABC heterotrimeric nanoparticles was synthesized through a one-pot surfactant free process under alkaline condition in alcohol-water system. Typically, 3-aminophenol (0.41 g), formalin (37 wt %, 0.9 mL), and tetraethyl orthosilicate (TEOS, 1.75 mL) were added to the solution composed of ammonia aqueous solution (1.56 mL, 28 wt %), deionized water (10 mL), ethylenediamine (EDA, 0.175 mL) and ethanol (40 mL). The above solution was vigorously stirred at room temperature for 4 h. The as-synthesized particles were separated by centrifugation, and washed with ethanol and deionized water for three times. The final product was obtained by drying at 323 K overnight. The asymmetric silica nanoparticles were obtained by calcination of the pre-dried ABC heterotrimeric nanoparticles at 550° C. in air. Carbon product of the ABC heterotrimeric nanoparticles were achieved by calcining the sample under nitrogen atmosphere in a tube furnace at 700° C. with a heating rate of 3° C./min. Silica etching was carried out in an 8% HF aqueous solution.

[0064] Transmission electron microscope (TEM) images of the heterotrimeric nanoparticles (FIG. 3a, 3b) clearly showed an asymmetric nanostructure similar to the morphology of the fruit acorn, which is supported by the scanning electron microscopy (SEM) observations (FIG. 3c). The particles are monodispersed and uniform in size (˜420 nm). From TEM images, the “bulge” (block B) has a hemispherical morphology with a smaller contrast than the “cap” (block C)(FIG. 3b). Moreover, the “cap” has a core with darker contrast and a shell with spike-like fine nanostructures.

[0065] Scanning TEM (STEM) coupled with energy dispersive X-ray spectroscopy (EDS) elemental mapping (C, N, O, Si) was used to record the heterogeneous composition in the heterotrimeric nanoparticles (FIG. 3d-i). A STEM image (FIG. 3d) showed the same acorn-like morphology as FIG. 3a-c. The C (FIG. 3e) and N mapping (FIG. 3f) exhibited a higher intensity in the hemispherical “bulge” region, while the O (FIG. 3g) and Si (FIG. 3h) intensity was observed predominantly in the “cap” region. This heterogeneous distribution of C, N, O, Si elements was more evident in the overlapped image (FIG. 3i). The above results indicate that the acorn-like heterotrimeric nanoparticle has a structure as shown in FIG. 2: the “bulge” (block B) is composed of APF without SiO2, while the “cap” has a silica-rich core (block A) and a silica-APF composite shell (block C).

[0066] After removing APF polymer from the ABC heterotrimeric nanoparticles by calcination, well dispersed asymmetric silica nanoparticles (composed of block A and part of block C) are obtained. From the high magnification TEM images (FIG. 3a), the measured particle size is around 370 nm. It is found that the asymmetric silica nanoparticle has a solid silica core (˜230 nm in diameter). Noticeably, the silica core is densely coated by nano-sized silica spikes (˜70 nm in length) which attached only on one side of the silica sphere, leaving the other side uncovered, confirmed by the related SEM image (FIG. 2b). From the TEM images of asymmetric carbon nanoparticles, a high contrast “bulge” with hemispherical morphology and a hollow mesoporous “cap” structure is observed in the particle (FIG. 1c). The hollow morphology and asymmetric structure can be clearly identified through the TEM images. The particle size of the obtained asymmetric carbon nanoparticles is around 380 nm. The diameter of the cavity is similar to the size of the silica core in FIG. 1a, which further confirm existence of the solid silica core inside the “cap” of ABC heterotrimeric nanoparticles

[0067] Dynamic light scattering (DLS) measurement was carried out to analyse the dispersity and particle size of the ABC heterotrimeric nanoparticles, asymmetric silica nanoparticles and asymmetric carbon nanoparticles (Figure S1). DLS values show that all the three nanoparticles are monodispersed in water with a polydispersity index (PDI) less than 0.3. The measured hydrodynamic particle sizes of each nanoparticles are larger than their TEM results, which is caused by the hydration layer around silica nanoparticles..sup.53

[0068] To characterize the porous structure of the synthesized asymmetric nanoparticles, N.sub.2 sorption-desorption analysis was conducted. The results are presented in Figure S2. The nitrogen adsorption and desorption isotherm of asymmetric silica nanoparticles and asymmetric carbon nanoparticles show typical type IV isotherms as defined by IUPAC..sup.54 No porous structure can be observed for ABC heterotrimeric nanoparticles. Barrett-Joyner-Halenda (BJH) pore size distribution curve of asymmetric carbon nanoparticles in Figure S2 derived from adsorption branch exhibits a relatively broad peak centered at ˜13.9 nm. While for asymmetric silica nanoparticles, the pore size distribution curve is centered at ˜15.1 nm. Detailed textural parameters are listed in Table S1. The Brunauer-Emmett-Teller (BET) surface area and pore volume of asymmetric silica nanoparticles are 97.6 m.sup.2.Math.g.sup.−1 and 0.33 cm.sup.3.Math.g.sup.−1. For the asymmetric carbon nanoparticles, the BET surface area and pore volume are 954.3 m.sup.2.Math.g.sup.−1 and 1.93 cm.sup.3.Math.g.sup.−1, respectively.

[0069] For the morphology characterization of three-dimensional (3D) nanoparticles, especially for asymmetric nanoparticles, the overlapping features of conventional TEM may complicate the analysis of those nanostructures and provide misleading information. This is because the images obtained by TEM are 2D projections of 3D objects..sup.55,40,41 In the case of ABC heterotrimeric nanoparticles, the “cap” is larger than the “bulge”. When the electron beam passed from the “cap” to the “bulge”, it will result in the appearance of symmetric spheres as shown in FIG. 3a (indicated by arrows)..sup.56,57 Therefore, Electron tomography (ET) as a rapidly developing technique is applied for the morphology characterization of the ABC heterotrimeric nanoparticles and its second-generations. The related tilting TEM images are shown in FIG. 6. From FIG. 6a&b, one can see clearly the ABC heterotrimeric nanoparticle changing from an asymmetric structure to a spherical structure with a tilt axis ranging from +120° to 0°. As for asymmetric silica nanoparticles (FIG. 6d&e) and asymmetric carbon nanoparticles (FIG. 6g&h), asymmetric and symmetric structures can be clearly observed before (FIG. 6d&g) and after (FIG. 6e&h) tilting, respectively.

[0070] To study the detailed structures of the as prepared nanoparticles, ET slice cuts parallel to the symmetry axis from the center were generated by using IMOD software..sup.58 For the ABC heterotrimeric nanoparticle, ET slice (FIG. 6c) shows a three compartment structure, where the “bulge” and the “cap” can be easily seen. FIG. 6f presents that asymmetric silica nanoparticle has an obviously asymmetric morphology with only one side of the silica core coated by silica nano spikes. For asymmetric carbon nanoparticle, a hollow asymmetric structure was shown in FIG. 6i, the hollow void of which perfectly replicates the shape of the asymmetric silica nanoparticle as shown in FIG. 6f. This is consistent with the previous results.

[0071] In order to investigate the formation mechanism of the ABC heterotrimeric nanoparticles, a time-dependent study was conducted. Samples were collected with different reaction time (5 min, 10 min 15 min, 30 min, 1 h and 2 h) during preparation. TEM images of the as-synthesized samples are shown in FIG. 7. TEM images of their related silica products and carbon products are shown in FIG. 8 and FIG. 9, respectively. Under the reaction condition, the hydrolysis and condensation of TEOS first form silica spheres (particle size ˜100 nm) within 5 min (FIG. 7a and FIG. 8a) because TEOS reacts faster than the polymerization reaction of APF..sup.26,52 The relatively slower reaction kinetic rate of APF is revealed by FIG. 9a, since only disordered carbon structure can be found, which means 3-aminophenol and formaldehyde starts to form APF oligomers at ˜5 min., After 10 min of reaction, a small dense APF polymer “bulge” (block B, low contrast) grows on the silica core (block A) forming a asymmetric AB heterodimeric structure, as the related calcined sample show only the existence of silica sphere (˜160 nm) (FIG. 8b) and the related carbonized sample show the presence of a carbon “bulge” (FIG. 9b) which was coming from the “bulge” shagged APF polymer. The formation mechanism of the above asymmetric “head-tail” structure is similar to the classical island growth mode of Volmer-Weber..sup.59,60 By prolonging the reaction time to 15 min, the sizes of both blocks A and B increase with time (FIG. 7c, FIG. 8c and FIG. 9c) which is thermodynamically favored by the self-regulated homogeneous-heterogeneous nucleation mechanism..sup.12,61,62 After the formation of the AB heterodimeric structure, the third compartment (block C) starts to coat on block A at the reaction time of 30 min as shown in FIG. 7d It is interesting to notice that block B and block C both grow in size with the reaction going on (FIG. 7e&f) and the nanoparticles reached to a final size of ˜420 nm.

[0072] During the experiment, we noticed that the amount of EDA introduced into the reaction system played a key role in determining the structure of the obtained nanoparticles Therefore, an interaction modulated sequential asymmetric deposition mechanism is proposed accordingly. When no EDA or low amount of EDA was added, only homogeneous nucleation of APF polymer spheres and silica spheres can be observed (FIG. 10a,b&c), which can be easily understood that, due to the negatively charged properties of APF oligomer.sup.63 and in situ generated silica primary particles.sup.64, the interaction between silica primary particles and APF oligomer was limited which led to the formation of isolated APF polymer spheres and silica spheres.

[0073] With a higher EDA amount of 0.175 mL, the positive charged EDA functions as a binder, which can react with both the preformed silica cores and APF oligomers. Therefore, the interaction between silica primary particles and APF oligomer was enhanced, which is beneficial for the cooperative assembly. Under the EDA amount of 0.175 mL, since the nucleation and growth process of silica and APF polymer can be triggered at different time point due to the fast hydrolysis and condensation rate of silica precursor..sup.65 Block A was quickly formed as a stable colloidal suspension in the reaction mixture. The size of block A kept growing and the condensation rate of silica primary particles decreased as a result of the consumption of the silica precursors. At the same time, the polymerization rate of 3-aminophenol and formaldehyde start to accelerate as shown by the indication of the existence of amorphous APF polymer in Fig. S4a. When Block A reached to a size of ˜170 nm (FIG. 7b), the condensation rate of silica primary particles and the polymerization rate of APF became very close. Previous reports showed that if the polymerization rate of the two participant distinct a lot, only core-shell rather than asymmetric structures can be obtained..sup.66-68 Under the present of suitable amount of EDA and the similar polymerization rate of silica primary particles and APF oligomers, once the APF oligomer overcame the energy barrier for nucleation, under the heterogeneous nucleation mechanism,12′74 APF oligomer favoured to nucleate on the silica cores heterogeneously to reduce the surface energy (the formation of particle AB, as shown in FIG. 1, and FIG. 7b)..sup.69,70 As a result, the in situ generated silica cores is partially deposited by APF oligomers, which lead to the formation of the observable APF “bulge” domain in the final asymmetric ABC heterotrimeric nanoparticle.

[0074] At the time when block B asymmetric deposited on one side of block A, a large amount of silica precursor had been consumed to form block A, which means limited amount of silicate oligomers exist in the reaction solution. With the help of EDA, the existed silicate oligomers can react with phenolic resin to form some phenol-containing silicate oligomers species..sup.71,72 At this stage, APF oligomers and the phenol-containing silicate oligomers are predominant and coexist in the solution. For APF oligomers, it will continue to deposit on block B (C—O—C bond rich) since the same chemical composition. While for the phenol-containing silicate oligomers, it prefer to further condense on the silica domain part (block A, Si—O—Si bond rich). As a result of the competitive and cooperative assembly process between silica primary particles and APF oligomer, a “cap” (block C) can be found coating on the silica domain of AB heterodimeric nanoparticle forming the ABC heterotrimeric nanoparticles.

[0075] When further increase the EDA amount to 0.200 mL, more formalin was consumed by EDA to form Schiff base accordingly..sup.26,73 Therefore, less APF precursors was available for the formation of the APF “bulge” resulting in the decrease of the “bulge” domain (block B) of the ABC heterotrimeric nanoparticles, as pointed by the arrows in FIG. 10d,e&f. A further higher EDA amount (0.215 mL) consumes more formalin and favors the heterogeneous nucleation of APF polymer and silica forming symmetric APF/silica composite (FIG. 10g) with no APF “bulge” domain. By calcination, the APF/silica composite can be converted to symmetric silica nanoparticles (FIG. 10h) where the nano spikes-like silica subunit symmetrically coated on the silica core surface, and hollow mesoporous carbon spheres (FIG. 10i) can be obtained by the carbonization and HF etching of silica of the APF/silica composite. This demonstrate the symmetric morphology of the APF/silica composite synthesized at the higher EDA amount (0.215 mL).

Example 3

[0076] We further investigated the cellular uptake performance between the asymmetric silica nanoparticles and a symmetric silica nanoparticles (sample from FIG. 10h) in RAW 264.7 cells, HCT116 cells, CHO-K1 cells and KHOS cells. We quantified the cellular uptake amount of each silica nanoparticles by measuring the total amounts of silicon by ICP-OES. The cellular uptake results at different incubation time points (0.5 h, 2 h and 4 h) are shown as the amount of silicon per cell in FIG. 11. From the figure, it is obvious to see that, for cells with high phagocytic capacity (RAW 264.7 and HCT116 cells), the asymmetric silica nanoparticles show higher cellular uptake amount than the symmetric silica nanoparticles at each incubation time point. For instance, in macrophage RAW 264.7 cell line, ˜20 pg of the asymmetric silica nanoparticles was uptaken by each cell after incubation at 37° C. for 0.5 h. while only ˜10 pg of the symmetric silica nanoparticles per cell was uptaken after the same incubation time. With the increase of nanoparticle and cell incubation time, both the cellular uptake amount of the asymmetric silica nanoparticles and the symmetric silica nanoparticles increase. And the asymmetric silica nanoparticles still show higher uptake amount than the symmetric silica nanoparticles. This result means that for cell lines with relative high phagocytic capacity (RAW 264.7 and HCT116 cells), they preferentially uptake the asymmetric silica nanoparticle with asymmetric structure where the surface is asymmetrically coated by silica nano spikes rather than the symmetric silica nanoparticles with nano spikes symmetrically coating on the silica core surface.

[0077] However, it is noteworthy that the cellular uptake results for cell lines with low phagocytic capacity show completely opposite preference compared with the previous results. As shown in FIG. 6c, the symmetric silica nanoparticles were internalized into CHO-K1 cells with higher amount (˜6 pg/cell) then the asymmetric silica nanoparticle (˜3 pg/cell) at incubation time of 0.5 h, and the uptake amounts of the two type nanoparticles increased during the following hours. At the incubation time of 4 h, the symmetric silica nanoparticle uptake by CHO-K1 cells reach to ˜17 pg/cell, which was much higher than that for the asymmetric silica nanoparticles (˜5 pg/cell). Similar observations can be found in KHOS cell line.

[0078] After evaluating the cellular uptake performance of the asymmetric silica nanoparticles and the symmetric silica nanoparticles among RAW 264.7, HCT116 cells, CHO-K1 and KHOS cells lines by ICP-OES, we were interested if the phagocytic capacity of different cells might play a role in the uptake process of the nanoparticles. Previous report has shown that the shape of nanoparticles plays a dominant role in activate the phagocytosis pathway..sup.45 We investigated whether the distinct cellular uptake preferences of the two silica nanoparticles with different surface symmetry are resulted from the phagocytic capacity different among the four cell lines. To establish the role of the phagocytic capacity of a cell line on the nanoparticles' internalization, we conducted a confocal analysis. To observe the activation of the phagocytosis pathway, we use rhodamine phalloidin (RH phalloidin) to stain the actin filaments which is usually involved in the phagocytosis process..sup.74-76 The functionality of the phagocytosis pathway can be verified via the red fluorescence from the confocal images. FIG. 12 show the confocal microscopy images of RAW 264.7 and HCT116 cells incubated with asymmetric silica and symmetric silica nanoparticles at various incubation times (0.5 h, 2 h, 4 h), respectively. As shown in FIG. 12, from the internalization result of the cells with higher phagocytic capacity (RAW 264.7 and HCT116),.sup.34,77,7831,72,73 the phagocytosis pathway is activated at very early time point (0.5 h) as shown by the red fluorescence. For example, for the uptake of asymmetric silica nanoparticle, as shown in the confocal image result of RAW 264.7 cell line at 0.5 h. The cells presented a peripheral red fluorescent label that show clearly the spatial cell morphology. The short time course of particle uptake by macrophage phagocytosis pathway is consistent with previous report..sup.79 The limited red fluorescent can be observed at incubation time of 2 h and 4 h for RAW 264.7 cell line, which means the phagocytosis process is relative weak after the initial fast internalization stage. Similar results was found in the uptake of the asymmetric silica nanoparticle in HCT116 cell line (FIG. 12), which shows that the phagocytosis pathway of HCT116 cells can be easily activated by the asymmetric silica nanoparticles. However, for the cellular uptake of the symmetric silica nanoparticles in RAW264.7 and HCT116 cell lines, as judged by the red fluorescent intensity of the confocal images in FIG. 12, the phagocytic pathway of both RAW264.7 and HCT116 cell lines can be activated at short incubation time of the symmetric silica nanoparticles with the cells. However, the fluorescent intensity is less strong as compared with that of the asymmetric silica nanoparticles. The fast activation of phagocytosis pathway of RAW264.7 and HCT116 cells by the incubation of the asymmetric or symmetric nanoparticles further demonstrate the high phagocytic capacity of the two cell lines, which is consistent with previous reports..sup.40,81,82 And these two cell lines uptake more of the asymmetric silica nanoparticle over the symmetric silica nanoparticles.

[0079] FIG. 13 shows the actin filaments staining results of CHO-K1 and KHOS cells with different nanoparticle and cell incubation time (0.5 h, 2 h and 4 h). From the figure, the phagocytosis of two nanoparticles in CHO-K1 cells started after 4 h of incubation, which is much delayed compared with RAW 264.7 and HCT116 cell lines, suggesting the CHO-K1 cell can display relative low extend phagocytic activity..sup.80-82 While the phagocytosis pathway of KHOS cells was not activated during the experiment (up to 4 h), which is consistent with the negligible phagocytic capacity of KHOS cells. Our results provide direct comparison between asymmetric and symmetric nanoparticles with the phagocytic capacity of a cell line.

[0080] To further evaluate the contribution of the actin polymerization based phagocytosis to the cellular uptake of each type of nanoparticles, we set out to investigate cellular uptake of the two silica nanoparticles by applying a phagocytosis pathway inhibitor cytochalasin D (denoted as Cyto D) which is widely used to disrupt actin polymerization..sup.83,84 Nanoparticles uptake by each cell line was measured at short incubation time (0.5 h) due to the reason that the blocking of one uptake pathway can activate other endocytic pathways..sup.85,86 In the control group, where no inhibitor was introduced, we compared the cellular uptake level of the symmetric silica and the asymmetric silica nanoparticles in each cell lines. Rhodamine-B-isothiocyanate (RITC) was conjugated to the silica nanoparticles, the normalized cell-associated mean fluorescence intensity was analysed by fluorescence-activated cell sorting (FACS) (FIG. 14). In the figure, the cellular uptake evaluated by FACS show a similar trend compared with the ICP result in FIG. 11. After the introduction of the pathway inhibitor Cyto D, the result is shown in FIG. 13. For cell lines with low phagocytic capacity (KHOS and CHO-K1 cell lines), the block of actin polymerization by Cyto D did not significantly influence the uptake result of nanoparticles regardless of the nanoparticle is symmetric or asymmetric. However, the nanoparticles internalization was reduced to some extend by Cyto D in HCT116 cells, especially for the asymmetric silica nanoparticle, which show significant difference compared to the control group. Moreover, with the increase of the phagocytic capacity of the cells, for RAW264.7 cells, 35% of inhibition can be observed for the asymmetric silica nanoparticles. This suggests that the phagocytosis pathway participated strongly in the endocytosis of the asymmetric silica nanoparticles. This result signifies that the phagocytic capacity of a cell line has significant influence on the cellular uptake preference between the asymmetric silica nanoparticles and the symmetric silica nanoparticles.

[0081] In the present specification and claims (if any), the word ‘comprising’ and its derivatives including ‘comprises’ and ‘comprise’ include each of the stated integers but does not exclude the inclusion of one or more further integers.

[0082] Reference throughout this specification to ‘one embodiment’ or ‘an embodiment’ means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the appearance of the phrases ‘in one embodiment’ or ‘in an embodiment’ in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more combinations.

[0083] In compliance with the statute, the invention has been described in language more or less specific to structural or methodical features. It is to be understood that the invention is not limited to specific features shown or described since the means herein described comprises preferred forms of putting the invention into effect. The invention is, therefore, claimed in any of its forms or modifications within the proper scope of the appended claims (if any) appropriately interpreted by those skilled in the art.

CITATION LIST

[0084] 1. Du, J.; O'Reilly, R. K. Chemical Society reviews 2011, 40, 2402. [0085] 2. Hu, J.; Zhou, S.; Sun, Y.; Fang, X.; Wu, L. Chemical Society reviews 2012, 41, 4356. [0086] 3. Hodges, J. M.; Schaak, R. E. Accounts of Chemical Research 2017. [0087] 4. Jiang, S.; Granick, S.; Schneider, H.-J. Janus particle synthesis, self-assembly and applications; Royal Society of Chemistry, 2012. [0088] 5. Wang, C.; Xu, C.; Zeng, H.; Sun, S. Advanced materials 2009, 21, 3045. [0089] 6. Lattuada, M.; Hatton, T. A. Nano Today 2011, 6, 286. [0090] 7. Feyen, M.; Weidenthaler, C.; Schüth, F.; Lu, A.-H. Journal of the American Chemical Society 2010, 132, 6791. [0091] 8. Jiang, S.; Schultz, M. J.; Chen, Q.; Moore, J. S.; Granick, S. Langmuir: the ACS journal of surfaces and colloids 2008, 24, 10073. [0092] 9. Lattuada, M.; Hatton, T. A. Journal of the American Chemical Society 2007, 129, 12878. [0093] 10. HoonáKim, S.; WonáNam, S.; WooaCheong, I. Chemical communications 2011, 47, 2634. [0094] 11. Casavola, M.; Buonsanti, R.; Caputo, G.; Cozzoli, P. D. European Journal of Inorganic Chemistry 2008, 2008, 837. [0095] 12. Carbone, L.; Cozzoli, P. D. Nano Today 2010, 5, 449. [0096] 13. Crane, C. C.; Tao, J.; Wang, F.; Zhu, Y.; Chen, J. The Journal of Physical Chemistry C 2014, 118, 28134. [0097] 14. Schick, I.; Lorenz, S.; Gehrig, D.; Schilmann, A.-M.; Bauer, H.; Panthofer, M.; Fischer, K.; Strand, D.; Laquai, F.; Tremel, W. Journal of the American Chemical Society 2014, 136, 2473. [0098] 15. Bradley, M. J.; Read, C. G.; Schaak, R. E. The Journal of Physical Chemistry C 2015, 119, 8952. [0099] 16. Hodges, J. M.; Morse, J. R.; Williams, M. E.; Schaak, R. E. Journal of the American Chemical Society 2015, 137, 15493. [0100] 17. Read, C. G.; Gordon, T. R.; Hodges, J. M.; Schaak, R. E. Journal of the American Chemical Society 2015, 137, 12514. [0101] 18. Amirav, L.; Alivisatos, A. P. The Journal of Physical Chemistry Letters 2010, 1, 1051. [0102] 19. Khon, E.; Lambright, K.; Khnayzer, R. S.; Moroz, P.; Perera, D.; Butaeva, E.; Lambright, S.; Castellano, F. N.; Zamkov, M. Nano letters 2013, 13, 2016. [0103] 20. Buck, M. R.; Schaak, R. E. Angewandte Chemie International Edition 2013, 52, 6154. [0104] 21. Scarfiello, R.; Nobile, C.; Cozzoli, P. D. Frontiers in Materials 2016, 3, 56. [0105] 22. Reculusa, S.; Poncet-Legrand, C.; Perro, A.; Duguet, E.; Bourgeat-Lami, E.; Mingotaud, C.; Ravaine, S. Chemistry of Materials 2005, 17, 3338. [0106] 23. Qu, L.; Hu, H.; Yu, J.; Yu, X.; Liu, J.; Xu, Y.; Zhang, Q. Langmuir: the ACS journal of surfaces and colloids 2017. [0107] 24. Tran, N.; Mulet, X.; Hawley, A. M.; Conn, C. E.; Zhai, J.; Waddington, L. J.; Drummond, C. J. Nano letters 2015, 15, 4229. [0108] 25. Zhao, J.; Niu, W.; Zhang, L.; Cai, H.; Han, M.; Yuan, Y.; Majeed, S.; Anjum, S.; Xu, G. Macromolecules 2012, 46, 140. [0109] 26. Liu, Y.; Zhang, H.; Noonan, O.; Xu, C.; Niu, Y.; Yang, Y.; Zhou, L.; Huang, X.; Yu, C. Chemistry—A European Journal 2016, 22, 14962. [0110] 27. Li, Z.; Barnes, J. C.; Bosoy, A.; Stoddart, J. F.; Zink, J. I. Chemical Society reviews 2012, 41, 2590. [0111] 28. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nature nanotechnology 2007, 2, 751. [0112] 29. Stark, W. J. Angewandte Chemie International Edition 2011, 50, 1242. [0113] 30. Mao, Z.; Zhou, X.; Gao, C. Biomaterials science 2013, 1, 896. [0114] 31. Oh, N.; Park, J.-H. International journal of nanomedicine 2014, 9, 51. [0115] 32. Kettler, K.; Veltman, K.; van de Meent, D.; van Wezel, A.; Hendriks, A. J. Environmental toxicology and chemistry 2014, 33, 481. [0116] 33. Conner, S. D.; Schmid, S. L. Nature 2003, 422, 37. [0117] 34. Aderem, A.; Underhill, D. M. Annual review of immunology 1999, 17, 593. [0118] 35. Rabinovitch, M. Trends in cell biology 1995, 5, 85. [0119] 36. Gagnon, E.; Duclos, S.; Rondeau, C.; Chevet, E.; Cameron, P. H.; Steele-Mortimer, O.; Paiement, J.; Bergeron, J. J.; Desjardins, M. Cell 2002, 110,119. [0120] 37. Kucharzik, T.; Lugering, N.; Rautenberg, K.; Liigering, A.; Schmidt, M.; Stoll, R.; Domschke, W. Annals of the New York Academy of Sciences 2000, 915, 171. [0121] 38. Lee, C. S.; Penberthy, K. K.; Wheeler, K. M.; Juncadella, I. J.; Vandenabeele, P.; Lysiak, J. J.; Ravichandran, K. S. Immunity 2016, 44, 807. [0122] 39. Neutra, M. R.; Frey, A.; Kraehenbuhl, J.-P. Cell 1996, 86, 345. [0123] 40. Dasgupta, S.; Auth, T.; Gompper, G. Nano letters 2014, 14, 687. [0124] 41. Mitragotri, S.; Lahann, J. Nature materials 2009, 8, 15. [0125] 42. Best, J. P.; Yan, Y.; Caruso, F. Advanced healthcare materials 2012, 1, 35. [0126] 43. Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. Nano letters 2006, 6, 662. [0127] 44. Chithrani, B. D.; Chan, W. C. Nano letters 2007, 7, 1542. [0128] 45. Champion, J. A.; Mitragotri, S. Proceedings of the National Academy of Sciences of the United States of America 2006, 103, 4930. [0129] 46. Möller, J.; Luehmann, T.; Hall, H.; Vogel, V. Nano letters 2012, 12, 2901. [0130] 47. Herd, H.; Daum, N.; Jones, A. T.; Huwer, H.; Ghandehari, H.; Lehr, C.-M. ACS nano 2013, 7, 1961. [0131] 48. Blechinger, J.; Bauer, A. T.; Torrano, A. A.; Gorzelanny, C.; Brauchle, C.; Schneider, S. W. Small 2013, 9, 3970. [0132] 49. Wang, W.; Wang, P.; Tang, X.; Elzatahry, A. A.; Wang, S.; Al-Dahyan, D.; Zhao, M.; Yao, C.; Hung, C.-T.; Zhu, X. ACS central science 2017, 3, 839. [0133] 50. Song, H.; Ahmad Nor, Y.; Yu, M.; Yang, Y.; Zhang, J.; Zhang, H.; Xu, C.; Mitter, N.; Yu, C. Journal of the American Chemical Society 2016, 138, 6455. [0134] 51. Carcouet, C. C.; van de Put, M. W.; Mezari, B.; Magusin, P. C.; Laven, J.; Bomans, P. H.; Friedrich, H.; Esteves, A. C. C.; Sommerdijk, N. A.; van Benthem, R. A. Nano letters 2014, 14, 1433. [0135] 52. Bogush, G.; Zukoski, C. Journal of colloid and interface science 1991, 142, 1. [0136] 53. Tolnai, G.; Csempesz, F.; Kabai-Faix, M.; Kalman, E.; Keresztes, Z.; Kovacs, A.; Ramsden, J.; Horvolgyi, Z. Langmuir: the ACS journal of surfaces and colloids 2001,17, 2683. [0137] 54. Sing, K. S. Pure and applied chemistry 1985, 57, 603. [0138] 55. Lobling, T. I.; Haataja, J. S.; Synatschke, C. V.; Schacher, F. H.; Müller, M.; Hanisch, A.; Groschel, A. H.; Müller, A. H. ACS nano 2014, 8, 11330. [0139] 56. Friedrich, H.; de Jongh, P. E.; Verkleij, A. J.; de Jong, K. P. Chemical reviews 2009, 109, 1613. [0140] 57. Zhang, H.; Yu, M.; Song, H.; Noonan, O.; Zhang, J.; Yang, Y.; Zhou, L.; Yu, C. Chem. Mater 2015, 27, 6297. [0141] 58. Kremer, J. R.; Mastronarde, D. N.; McIntosh, J. R. Journal of structural biology 1996, 116, 71. [0142] 59. Peng, Z.; Yang, H. Nano Today 2009, 4, 143. [0143] 60. Goebl, J. A.; Black, R. W.; Puthussery, J.; Giblin, J.; Kosel, T. H.; Kuno, M. Journal of the American Chemical Society 2008, 130, 14822. [0144] 61. Costi, R.; Saunders, A. E.; Banin, U. Angewandte Chemie International Edition 2010, 49, 4878. [0145] 62. Saunders, A. E.; Popov, I.; Banin, U. Zeitschrift für anorganische and allgemeine Chemie 2007, 633, 2414. [0146] 63. Arif, A. F.; Kobayashi, Y.; Balgis, R.; Ogi, T.; Iwasaki, H.; Okuyama, K. Carbon 2016, 107, 11. [0147] 64. Kobayashi, M.; Skarba, M.; Galletto, P.; Cakara, D.; Borkovec, M. Journal of colloid and interface science 2005, 292, 139. [0148] 65. Erdemir, D.; Lee, A. Y.; Myerson, A. S. Accounts of chemical research 2009, 42, 621. [0149] 66. Qu, L.; Hu, H.; Yu, J.; Yu, X.; Liu, J.; Xu, Y.; Zhang, Q. Langmuir: the ACS journal of surfaces and colloids 2017, 33, 5269. [0150] 67. Fuertes, A. B.; Valle-Vigon, P.; Sevilla, M. Chemical communications 2012, 48, 6124. [0151] 68. Yang, P.; Xu, Y.; Chen, L.; Wang, X.; Mao, B.; Xie, Z.; Wang, S.-D.; Bao, F.; Zhang, Q. Nano letters 2015, 15, 8397. [0152] 69. Wang, J.; Tsung, C.-K.; Hong, W.; Wu, Y.; Tang, J.; Stucky, G. D. Chemistry of materials 2004, 16, 5169. [0153] 70. Zhang, L.; Zhang, F.; Dong, W.-F.; Song, J.-F.; Huo, Q.-S.; Sun, H.-B. Chemical communications 2011, 47, 1225. [0154] 71. Song, J.-C.; Xue, F.-F.; Zhang, X.-X.; Lu, Z.-Y.; Sun, Z.-Y. Chemical communications 2017, 53, 3761. [0155] 72. Liu, R.; Shi, Y.; Wan, Y.; Meng, Y.; Zhang, F.; Gu, D.; Chen, Z.; Tu, B.; Zhao, D. Journal of the American Chemical Society 2006, 128, 11652. [0156] 73. Rivera, A.; Rios-Motta, J. Tetrahedron letters 2005, 46, 5001. [0157] 74. Welch, M. D.; Mullins, R. D. Annual review of cell and developmental biology 2002, 18, 247. [0158] 75. Dramsi, S.; Cossart, P. Annual review of cell and developmental biology 1998, 14, 137. [0159] 76. Allen, L.-A. H.; Aderem, A. Current opinion in immunology 1996, 8, 36. [0160] 77. Savill, J.; Wyllie, A.; Henson, J.; Walport, M.; Henson, P.; Haslett, C. The Journal of clinical investigation 1989, 83, 865. [0161] 78. Sanjuan, M. A.; Dillon, C. P.; Tait, S. W.; Moshiach, S.; Dorsey, F.; Connell, S.; Komatsu, M.; Tanaka, K.; Cleveland, J. L.; Withoff, S. Nature 2007, 450, 1253. [0162] 79. Geiser, M. Journal of aerosol medicine and pulmonary drug delivery 2010, 23, 207. [0163] 80. Bozue, J.; Moody, K. L.; Cote, C. K.; Stiles, B. G.; Friedlander, A. M.; Welkos, S. L.; Hale, M. L. Infection and immunity 2007, 75, 4498. [0164] 81. Frampton, A. R.; Stolz, D. B.; Uchida, H.; Goins, W. F.; Cohen, J. B.; Glorioso, J. C. Journal of virology 2007, 81, 10879. [0165] 82. Martin, C.; Etxaniz, A.; Uribe, K. B.; Etxebarria, A.; Gonzalez-Bullon, D.; Arlucea, J.; F. M.; Arechaga, J.; Ostolaza, H. Scientific reports 2015, 5, 13774. [0166] 83. Huang, J.-L.; Jiang, G.; Song, Q.-X.; Gu, X.; Hu, M.; Wang, X.-L.; Song, H.-H.; Chen, L.-P.; Lin, Y.-Y.; Jiang, D. Nature communications 2017, 8, 15144. [0167] 84. Metavarayuth, K.; Sitasuwan, P.; Zhao, X.; Lin, Y.; Wang, Q. ACS Biomaterials Science & Engineering 2016, 2, 142. [0168] 85. Ivanov, A. I. In Exocytosis and Endocytosis; Springer: 2008, p 15. [0169] 86. Dos Santos, T.; Varela, J.; Lynch, I.; Salvati, A.; Dawson, K. A. PloS one 2011, 6, e24438.